中軸性關節炎｜僵直性脊椎炎｜無放射影像確認之中軸關節炎 軟Q中炎院，分享專屬於中軸性脊椎關節炎的所有大小事 用懂你的語言，陪你度過不為人知的痛， 用簡單易懂的方式，讓大家了解與病共處的關鍵要領， 邀請到全台各院醫師，幫助大家一起終結炎症蔓延 -- Hosting provided by SoundOn
Language
🇨🇳
Publishing Since
5/20/2021
Email Addresses
1 available
Phone Numbers
0 available
November 8, 2023
僵直性脊椎炎的成因有哪些？ 僵直性脊椎炎目前最新的治療和日常該怎麼照顧？ 僵直性脊椎炎的患者該怎麼動？ 特別邀請到台北榮民總醫院風濕過敏免疫科陳明翰主任、曹彥博主治醫師醫師、歐道昇主治醫師及台北榮民總醫院復健科歐道昇主治醫師針對病友的常見問題來解答。 時間軸： 知脊知彼- 您該知道僵直性脊椎炎大小事-曹彥博醫師 00:00:00-00:37:50 萬壽無「僵」- 僵直性脊椎炎的治療與日常照顧- 歐道昇 醫師 00:37:51-01:00:04 化解「僵」局 – 僵直性脊椎炎該怎麼動?-楊怡強醫師 01:00:05-01:41:54 此集節目衛教合作單位：台灣諾華股份有限公司
December 22, 2022
僵直性脊椎炎還可以打籃球嗎？ 免煩惱學堂第三集！邀請到健身教練Ben，和各位分享除了藥物控制之外，平常透過哪些運動來進行保養。僵直性脊椎炎，除了積極透過藥物治療選擇對關節和脊椎傷害程度較低的運動，也可以幫助疾病日常照護喔！ 此集節目衛教合作單位：台灣諾華股份有限公司
December 20, 2022
免煩惱學堂第二集！林口長庚紀念醫院風濕過敏免疫科主治醫師蕭朝陽 來作客啦！ 僵直性脊椎炎可以推拿嗎？老是這裡痛、那裡酸，推拿或針灸有幫助嗎？ 此集節目衛教合作單位：台灣諾華股份有限公司
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.